Testing the "RCT augmentation" methodology: A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness.

Nordon, Clementine; Sanchez, Benoit; Zhang, Mei; Wang, Xiaowei; Hunt, Phillip; Belger, Mark; Karcher, Helene

Nordon, Clementine; Sanchez, Benoit; Zhang, Mei; Wang, Xiaowei; Hunt, Phillip; Belger, Mark; Karcher, Helene.

Afiliação

Nordon C; Formerly LASER Research, Paris, France.
Sanchez B; AstraZeneca, Gaithersburg, MD, United States of America.
Zhang M; Formerly LASER Research, Paris, France.
Wang X; Sanofi R&D, Bridgewater, NJ, United States of America.
Hunt P; Formerly GSK R&D Biostatistics, Collegeville, PA, United States of America.
Belger M; AstraZeneca, Gaithersburg, MD, United States of America.
Karcher H; Eli Lilly, Bracknell, United Kingdom.

Contemp Clin Trials Commun ; 33: 101142, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37397428